AP2886A - 6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disorders - Google Patents
6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disordersInfo
- Publication number
- AP2886A AP2886A AP2010005357A AP2010005357A AP2886A AP 2886 A AP2886 A AP 2886A AP 2010005357 A AP2010005357 A AP 2010005357A AP 2010005357 A AP2010005357 A AP 2010005357A AP 2886 A AP2886 A AP 2886A
- Authority
- AP
- ARIPO
- Prior art keywords
- treatment
- related disorders
- derivatives useful
- cancer related
- quinazoline derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2008/000036 WO2009090661A1 (en) | 2008-01-18 | 2008-01-18 | 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2010005357A0 AP2010005357A0 (en) | 2010-08-31 |
AP2886A true AP2886A (en) | 2014-05-31 |
Family
ID=39769348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2010005357A AP2886A (en) | 2008-01-18 | 2008-01-18 | 6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disorders |
Country Status (27)
Country | Link |
---|---|
US (5) | US8143250B2 (pl) |
EP (2) | EP3012251B1 (pl) |
JP (1) | JP2011509995A (pl) |
KR (2) | KR101762306B1 (pl) |
CN (1) | CN101918374A (pl) |
AP (1) | AP2886A (pl) |
AU (1) | AU2008347940A1 (pl) |
BR (1) | BRPI0822012A2 (pl) |
CA (1) | CA2711737C (pl) |
CY (1) | CY1118193T1 (pl) |
DK (2) | DK2229369T3 (pl) |
EA (1) | EA018514B1 (pl) |
ES (2) | ES2593321T3 (pl) |
HR (1) | HRP20161522T1 (pl) |
HU (1) | HUE030640T2 (pl) |
IL (1) | IL207046A (pl) |
LT (1) | LT2229369T (pl) |
MA (1) | MA32081B1 (pl) |
MX (1) | MX2010007852A (pl) |
NZ (1) | NZ586946A (pl) |
PL (1) | PL2229369T3 (pl) |
PT (1) | PT2229369T (pl) |
SG (1) | SG187490A1 (pl) |
SI (1) | SI2229369T1 (pl) |
UA (1) | UA101010C2 (pl) |
WO (1) | WO2009090661A1 (pl) |
ZA (1) | ZA201005116B (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011509995A (ja) * | 2008-01-18 | 2011-03-31 | ナトコ ファーマ リミテッド | 癌関連疾患の治療に有用な6,7−ジアルコキシキナゾリン誘導体 |
US9050341B2 (en) * | 2009-07-14 | 2015-06-09 | Natco Pharma Limited | Methods of treating drug resistant and other tumors by administering 6,7-dialkoxy quinazoline derivatives |
CN101857618B (zh) * | 2010-06-13 | 2015-11-25 | 中国海洋大学 | 作为蛋白酪氨酸激酶抑制剂的一系列喹唑啉糖衍生物,其制备方法和应用 |
JP2014532063A (ja) * | 2011-10-12 | 2014-12-04 | テリジェン リミテッドTeligene Ltd | キナーゼ阻害剤としてのキナゾリン誘導体およびその使用方法 |
TWI577671B (zh) * | 2011-11-14 | 2017-04-11 | Sunshine Lake Pharma Co Ltd | Aminoquinazoline derivatives and salts thereof and methods of use thereof |
EP2796451B1 (en) * | 2011-12-20 | 2018-08-01 | Wei Qian | Heterocycle amido alkyloxy substituted quinazoline derivative and use thereof |
WO2013142817A2 (en) | 2012-03-23 | 2013-09-26 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
US9771333B2 (en) | 2013-11-20 | 2017-09-26 | Signalchem Lifesciences Corp. | Quinazoline derivatives as TAM family kinase inhibitors |
KR20180086187A (ko) | 2015-10-05 | 2018-07-30 | 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 | 자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료 |
WO2018189747A1 (en) | 2017-04-15 | 2018-10-18 | Natco Pharma Limited | An improved process for the preparation of n-(3-ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy) quinazolin -4-amine dihydrochloride |
CN111499577A (zh) * | 2019-01-30 | 2020-08-07 | 华东师范大学 | 邻二苯基取代五元含氮芳杂环类类化合物及其应用 |
AU2022291015A1 (en) | 2021-06-10 | 2023-12-21 | Natco Pharma Limited | Egfr inhibitor for the treatment of head and neck cancer |
GB202108302D0 (en) * | 2021-06-10 | 2021-07-28 | Natco Pharma Ltd | New treatment |
CN115518071B (zh) * | 2021-06-24 | 2024-03-19 | 中国人民解放军联勤保障部队第九〇一医院 | 一种化合物在制备抗食管癌的药物中的应用 |
WO2024121861A1 (en) * | 2022-12-08 | 2024-06-13 | Natco Pharma Limited | Egfr inhibitor for the treatment of head and neck cancer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747498A (en) * | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US20070020261A1 (en) * | 2005-07-22 | 2007-01-25 | Sliwkowski Mark X | Combination therapy of her expressing tumors |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US690221A (en) | 1901-06-20 | 1901-12-31 | Frederik Christian Viggo Arp | Stand for cycles. |
US5332671A (en) * | 1989-05-12 | 1994-07-26 | Genetech, Inc. | Production of vascular endothelial cell growth factor and DNA encoding same |
US5183884A (en) * | 1989-12-01 | 1993-02-02 | United States Of America | Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
AU661533B2 (en) | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
US5811098A (en) * | 1992-11-24 | 1998-09-22 | Bristol-Myers Squibb Company | Antibodies to HER4, human receptor tyrosine kinase |
GB9323290D0 (en) | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
GB9314884D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Tricyclic derivatives |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
WO1996030347A1 (en) * | 1995-03-30 | 1996-10-03 | Pfizer Inc. | Quinazoline derivatives |
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US6706721B1 (en) * | 1998-04-29 | 2004-03-16 | Osi Pharmaceuticals, Inc. | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
UA74803C2 (uk) * | 1999-11-11 | 2006-02-15 | Осі Фармасьютікалз, Інк. | Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування |
WO2005070909A1 (en) | 2004-01-22 | 2005-08-04 | Natco Pharma Limited | An improved process for the preparation of gefitinib |
WO2006090413A1 (en) | 2005-02-23 | 2006-08-31 | Natco Pharma Limited | Novel crystalline form of gefitinib and a process for its preparation |
WO2007060691A2 (en) | 2005-11-23 | 2007-05-31 | Natco Pharma Limited | A novel process for the preparation of erlotinib |
JP2011509995A (ja) * | 2008-01-18 | 2011-03-31 | ナトコ ファーマ リミテッド | 癌関連疾患の治療に有用な6,7−ジアルコキシキナゾリン誘導体 |
-
2008
- 2008-01-18 JP JP2010542740A patent/JP2011509995A/ja active Pending
- 2008-01-18 US US12/812,726 patent/US8143250B2/en active Active
- 2008-01-18 NZ NZ586946A patent/NZ586946A/en unknown
- 2008-01-18 PT PT87200994T patent/PT2229369T/pt unknown
- 2008-01-18 PL PL08720099T patent/PL2229369T3/pl unknown
- 2008-01-18 CN CN2008801248191A patent/CN101918374A/zh active Pending
- 2008-01-18 DK DK08720099.4T patent/DK2229369T3/en active
- 2008-01-18 SG SG2013004064A patent/SG187490A1/en unknown
- 2008-01-18 EA EA201001173A patent/EA018514B1/ru unknown
- 2008-01-18 KR KR1020167018317A patent/KR101762306B1/ko active IP Right Grant
- 2008-01-18 BR BRPI0822012-3A patent/BRPI0822012A2/pt not_active Application Discontinuation
- 2008-01-18 SI SI200831672A patent/SI2229369T1/sl unknown
- 2008-01-18 ES ES08720099.4T patent/ES2593321T3/es active Active
- 2008-01-18 UA UAA201010197A patent/UA101010C2/ru unknown
- 2008-01-18 KR KR1020107015858A patent/KR101640161B1/ko active IP Right Grant
- 2008-01-18 AP AP2010005357A patent/AP2886A/xx active
- 2008-01-18 HU HUE08720099A patent/HUE030640T2/en unknown
- 2008-01-18 ES ES15199926.5T patent/ES2642159T3/es active Active
- 2008-01-18 AU AU2008347940A patent/AU2008347940A1/en not_active Abandoned
- 2008-01-18 MX MX2010007852A patent/MX2010007852A/es active IP Right Grant
- 2008-01-18 EP EP15199926.5A patent/EP3012251B1/en active Active
- 2008-01-18 WO PCT/IN2008/000036 patent/WO2009090661A1/en active Application Filing
- 2008-01-18 LT LTEP08720099.4T patent/LT2229369T/lt unknown
- 2008-01-18 CA CA2711737A patent/CA2711737C/en active Active
- 2008-01-18 EP EP08720099.4A patent/EP2229369B1/en active Active
- 2008-01-18 DK DK15199926.5T patent/DK3012251T3/en active
-
2010
- 2010-07-09 US US12/833,789 patent/US8921362B2/en active Active
- 2010-07-15 IL IL207046A patent/IL207046A/en active IP Right Grant
- 2010-07-19 ZA ZA2010/05116A patent/ZA201005116B/en unknown
- 2010-08-13 MA MA33089A patent/MA32081B1/fr unknown
-
2014
- 2014-12-26 US US14/583,286 patent/US9481655B2/en active Active
-
2016
- 2016-09-16 CY CY20161100921T patent/CY1118193T1/el unknown
- 2016-10-05 US US15/286,464 patent/US20170079983A1/en not_active Abandoned
- 2016-11-17 HR HRP20161522TT patent/HRP20161522T1/hr unknown
-
2019
- 2019-03-11 US US16/298,944 patent/US20190201408A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747498A (en) * | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US20070020261A1 (en) * | 2005-07-22 | 2007-01-25 | Sliwkowski Mark X | Combination therapy of her expressing tumors |
Non-Patent Citations (1)
Title |
---|
PARKINSON T. ET AL.: "An inhibitor of the epidermal growth factor receptor function does not affect the ability of human papillomavirus 11 to form warts in the xenografted immunodeflcient. mouse model" ANTIVIRAL RESEARCH, ELSEVIER SCIENCE BV., AMSTERDAM, NL, vol. 74, no. 1, 13 March 2007 (2007-03-13), pages 43-50 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2886A (en) | 6.7-Dialkoxy quinazoline derivatives useful for treatment of cancer related disorders | |
HK1254663A1 (zh) | 用於實體腫瘤的治療的布魯頓酪氨酸激酶的抑制劑 | |
IL241791A0 (en) | Historical use of 3,1-diphenylprop-2-en-1-one for the treatment of liver disorders | |
EP2170062A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER DISORDERS, TUMORS AND TUMOR-DISORDED DISEASES | |
AP2960A (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
PL2303021T3 (pl) | Związki do leczenia nowotworu | |
EP2260109A4 (en) | METHODS AND COMPOSITIONS BASED ON MICRO-RNA FOR DIAGNOSING, PROGNOSING AND TREATING PROSTATE-RELATED DISORDERS | |
ZA201006752B (en) | Spiro-indole derivatives for the treatment of parasitic disease | |
EP2224919A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS AND TUMOR-RELATED DISEASES | |
EP2331520A4 (en) | ROSAMINE DERIVATIVES AS AGENTS FOR CANCER TREATMENT | |
ZA201003425B (en) | 5-cyano-thienopyridines for the treatment of tumors | |
IL201562A0 (en) | Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases | |
IL210066A0 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
IL209417A0 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders | |
PL1982178T3 (pl) | Sposoby leczenia zaburzeń afektywnych | |
SI2278962T1 (sl) | Postopki za zdravljenje dermatoloških motenj | |
HK1209754A1 (en) | Compounds and methods for the treatment of cancer | |
GB0715257D0 (en) | Phenylthiazolylpiperazine derivatives for the treatment of nuero degenerative diseases | |
GB0604114D0 (en) | Combinations for the treatment of cancer |